ContraFect
ContraFect develops and commercializes biologic antibody therapeutics for the treatment of drug-resistant infectious diseases.
Business Model:
Revenue: $1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed ContraFect Information
Geographic Data
Address: 28 Wells Avenue
City: Yonkers
State: NY
Zip: 10701
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$58M
Raised Total:$113M
Social
Metrics
4,479,639Website Global Rank
2,165Website Monthly Traffic
Twitter Followers
Description
ContraFect develops and commercializes biologic antibody therapeutics for the treatment of drug-resistant infectious diseases.
Contact Phone:
+19142072300
Contact Email:
ContraFect went public on 7/29/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/29/2014
Ticker Symbol:
CFRX
Amount Raised:
$36M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Grant | 1 | $2.1M |
CARB-X CARB-X |
1/2019 | Grant | 1 | $2.3M |
CARB-X CARB-X CARB-X CARB-X |
7/2016 | Post-IPO Equity | $35M | 6/2015 | Post-IPO Equity | $20M | 11/2016 | Grant | $2.1M | 5/2020 | Post-IPO Equity | $52.5M | 12/2019 | Post-IPO Equity | $10M | 6/2019 | Grant | 1 | $7.2M |
Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs |
7/2018 | Post-IPO Equity | $10M | 3/2021 | Post-IPO Equity | $57.5M | 3/2019 | Grant | 1 | $6.9M |
CARB-X CARB-X CARB-X CARB-X |
3/2021 | Post-IPO Equity | $57.5M | 6/2015 | Post-IPO Equity | $20M | 1/2016 | Post-IPO Equity | $30M | 11/2016 | Grant | 1 | $2.1M |
U.S. Department of Defense U.S. Department of Defense |
12/2022 | Post-IPO Equity | $7M | 7/2020 | Grant | 1 | $18.9M |
CARB-X CARB-X CARB-X CARB-X |
8/2010 | Venture Round | 1 | $4.3M |
Equity Source Partners Equity Source Partners |
9/2013 | Debt Financing | $12M | 9/2011 | Venture Round | $0 |
Maxim Group Maxim Group |
7/2017 | Post-IPO Equity | $40M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
